- Harbige LS, Jones R, Jenkins R, Fitzgerald G, Forti A & Budowski P (1990) Nutritional management in multiple sclerosis with reference to experimental models. Ups J Med Sci 48, 189–207.
- Nightingale S, Woo E, Smith AD, et al. (1990) Red blood cell and adipose tissue fatty acids in mild inactive multiple sclerosis. Acta Neurol Scand 82, 43–50.
- Ota K, Matsui M, Milford EL, et al. (1990) T cell recognition of an immunodominant myelin basic epitope in multiple sclerosis. Nature 346, 183–187.
- Ruddle NH, Bergman CM, McGrath KM, et al. (1990) An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J Exp Med 172, 1193–1200.
- Swank RL & Dugan BB (1990) Effect of low saturated fat diet in early andlate cases ofmultiple sclerosis. Lancet, July7336,37–39.
- Karpus WJ & Swanborg RH (1991) CD4þ suppressor cells inhibit the function of effector cells of experimental autoimmune encephalomyelitis through a mechanism involving transforming growth factor-b. J Immunol 146, 1163–1168.
- Kuroda Y & Shimamoto Y (1991) Human tumor necrosis factor-alpha augments experimental allergic encephalomyelitis in rats. J Neuroimmunol 34, 159–164.
- Merrill JE & Zimmerman RP (1991) Natural and induced cytotoxicity of oligodendrocytes by microglia is inhibitable by TGF beta. Glia 4, 327–331. Murrell TGC, Harbige LS & Robinson IC (1991) A review of the aetiology of multiple sclerosis: an ecological approach. Ann Hum Biol. 18, 95–112.
- Selmaj K,RaineCS, FarooqM, et al. (1991)Cytokine cytotoxicity against oligodendrocytes. Apoptosis induced by lymphotoxin. J Immunol 147, 1522–1529.
- Sharief MK & Hentges R (1991) Association between tumour necrosis factor-alpha and disease progression in patients with multiple sclerosis. N. Engl. J. Med. 325, 467–472.
- Chou YK, Bourdette DN, Offner H, et al. (1992) Frequency of T cells specific for myelin basic protein and myelin proteolipid protein in blood and cerebrospinal fluid in multiple sclerosis. J Neuroimmunol 38, 105–114.
- Khoury SJ, Hancock WW & Weiner HL (1992) Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor b, interleukin 4, and prostaglandin E expression in the brain. J Exp Med 176, 1355–1364.
- Malosse D, Perron H, Sasco A & Seigneurin JM (1992) Correlation
between milk and dairy product consumption and multiple sclerosis prevalence: a worldwide study. Neuroepidemiology 11, 304–312.
- Sharief MK & Thompson EJ (1992) In vivo relationship of tumor necrosis factor-alpha to blood-brain barrier damage in patients with active multiple sclerosis. J Neuroimmunol 38, 27–33.
- Imamura K, Suzumura A, Hayashi F, et al. (1993) Cytokine production by peripheral blood monocytes/macrophages in multiple sclerosis patients. Acta Neurol Scand 87, 281–285.
- Kerlero de Rosbo N, Milo R, Lees MB, et al. (1993) Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein. J Clin Invest 92, 2602–8.
- Leventhal LJ, Boyce EG, Zurier RB, (1993) Treatment of rheumatoid arthritis with gammalinolenic acid, Ann Intern Med. 1993 Nov 1;119(9):867-73.
- Lu CZ, Jensen MA & Arnason BG (1993) Interferon gammaand interleukin-4-secreting cells in multiple sclerosis. J Neuroimmunol 46, 123–128.
- McCarron RM, Wang L, Racke MK, et al. (1993) Cytokine regulated
adhesion between encephalitogenic T lymphocytes and cerebrovascular endothelial cells. J Neuroimmunol 43, 23–30.
- Rack MK, Sriram S, Calrlini J, Cannella B, Raine CS & McFarlin DE (1993) Long-term treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-b2. J Neuroimmunol 46, 175–183.
- Santambrogio L, Hochwald GM, Saxena B, Leu CH, Martz JE, Carlino JA, Ruddle NH, Palladino MA, Gold LI & Thorbecke GJ (1993) Studies on the mechanisms by which Transforming Growth Factor-b protects against allergic encephalomyelitis. J Immunol 151, 1116–1127.
- Amor S, Groome N, Linington C, Morris MM, Dornmair K, Gardinier MV, Matthieu J M and Baker D (1994) Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice, The Journal of Immunology November 15, 1994 vol. 153 no. 10 4349-4356
- Fredrikson S, Soderstrom M, Hillert J, et al. (1994) Multiple sclerosis: occurrence of myelin basic protein peptide-reactive T cells in healthy family members. Acta Neurol Scand 89, 184–189.
- Mokhtarian F, Shi Y, Shirazian D, et al. (1994) Defective production of anti-inflammatory cytokine, TGF-beta by T cell lines of patients with active multiple sclerosis. J Immunol 152, 6003–6010.
- Rieckmann P, Albrecht M, Kitze B, et al (1994) Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis. Neurology 44, 1523–1526.
- Zhang J, Markovic-Plese S, Lacet B, et al. (1994) Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J Exp Med 179, 973–984.
- Cannella B & Raine CS (1995) The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann Neurol 37, 424–435.
- Esparza ML, Sasaki S & Kesteloot H (1995) Nutrition, latitude, and multiple sclerosis mortality: an ecologic study. Am. J. Epidemiol. 142, 733–737.
- Harbige LS, Yeatman N, Amor S & Crawford MA (1995) Prevention of experimental autoimmune encephalomyelitis in Lewis rats by a novel source of g-linolenic acid. Br J Nutr 74, 701–715.
- Liblau RS, Singer SM & McDevitt (1995) Th1 and Th2 CD4þT cells in the pathogenesis of organ-specific autoimmune diseases. Immunology Today 16, 34–38.
- VartanianT,LiY,ZhaoM, et al. (1995) Interferon-gamma-induced oligodendrocyte cell death: implications for the pathogenesis of multiple sclerosis. Mol Med 1, 732–743.
- Huang, Y.-S. and Mills, D. E. (Eds.), (1996). Gamma-linolenic acid metabolism and its roles in nutrition and medicine. AOCS Press, Champagne, Illinois, 319 pp.
- Issazadeh S, Lorentzen JC, Mustafa MI, et al. (1996) Cytokines in relapsing experimental autoimmune encephalomyelitis in DA rats: persistent mRNA expression of proinflammatory cytokines and absent expression of interleukin-10 and transforming growth factor-beta. J Neuroimmunol 69, 103–115.
- Navikas V & Link H (1996) Review: cytokines and the pathogenesis of multiple sclerosis. J Neurosci Res 45, 322–333.
- Philippe J, Debruyne J, Leroux-Roels G, et al. (1996) In vitro TNF-alpha, IL-2 and IFN-gamma production as markers of relapses in multiple sclerosis. Clin Neurol Neurosurg 98, 286–290.
- Serafina S, Sanchez M, Campeggi L, Suchanek G, Breitschop H & Lassmann H (1996) Accelerated myelinogenesis by dietary lipids in rat brain. Journal Neurochemistry 67, 1744–1750.
- Crawford MA, Costeloe K, Ghebremeskel K, et al. (1997) Are deficits of arachidonic and docosahexaenoic acids responsible for the neural and vascular complications of preterm babies. Am. J. Clin. Nutr. 66, Suppl, 1032S–41S.
- Harbige LS, Layward L, Morris M, Amor S (1997), Protective mechanisms by omega-6 lipids in experimental autoimmune encephalomyelitis (EAE) are associated with cytokines and eicosanoids, Biochemical Society transactions 1997;25(2):342S.
- Harbige LS, Layward L, Morris MM, Amor S, (1997), Cytokine secretion by human T cell clones is differentially regulated by eicosanoids, Biochemical Society transactions 1997;25(2):347S.
- Kerlero de Rosbo N, Hoffman M, Mendel I, et al. (1997) Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: reactivity to the extracellular domain of MOG is directed against three main regions. Eur J Immunol 27, 3059–69.
- Ewing C & Bernard CC (1998) Insights into the aetiology and pathogenesis of multiple sclerosis, Immunol Cell Biol. 76, 47–54.
- Ghadirian P, Jain M, Ducic S, et al. (1998) Nutritional factors in the aetiology of multiple sclerosis: a case-control study in Montreal, Canada. Int J Epidemiol. 27, 845–852.
- Harbige LS, (1998) Dietary n-6 and n-3 fatty acids in immunity and autoimmune disease, Proc. Nut. Scot. 57, 555-562
- Martino G & Hartung H-P (1999) Immunopathogenesis of multiple sclerosis: the role of T cells. Curr Opin Neurol 12, 309–321
- Bertolotto A, Capobianco M, Malucchi S, et al. (1999) Transforming
growth factor beta1 (TGFbeta1) mRNA level correlates with magnetic resonance imaging disease activity in multiple sclerosis patients. Neurosci Lett 263, 21–4.
- Bertolotto A, Malucchi S, Capobianco M, et al. (1999) Quantitative PCR reveals increased levels of tumor necrosis factoralpha mRNA in peripheral blood mononuclear cells of multiple sclerosis patients during relapses. J Interferon Cytokine Res 19, 575–581.
- Burns J, Bartholomew B & Lobo S (1999) Isolation of myelin basic protein-specific T cells predominantly from the memory T-cell compartment in multiple sclerosis. Ann Neurol 45, 33–39.
- Genain CP, Cannella B, Hauser SL, Raine CS. (1999), Identification of autoantibodies associated with myelin damage in multiple sclerosis, Nat Med. 1999 Feb;5(2):170-5.
- Noseworthy JH (1999) Progress in determining the causes and treatment of multiple sclerosis, Nature 399, Suppl. 24, A40–A46